These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 33315506)
1. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway. Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of MicroRNA-494 inhibits the TGF-β1/Smads signaling pathway and prevents the development of hypospadias through upregulating Nedd4L. Tian RH; Guo KM; Han GH; Bai Y Exp Mol Pathol; 2020 Aug; 115():104452. PubMed ID: 32413360 [TBL] [Abstract][Full Text] [Related]
3. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression. Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937 [TBL] [Abstract][Full Text] [Related]
4. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Liu L; Pang X; Shang W; Feng G; Wang Z; Wang J Ren Fail; 2020 Nov; 42(1):513-522. PubMed ID: 32441195 [No Abstract] [Full Text] [Related]
5. AUF1 modulates TGF-β signal in renal tubular epithelial cells via post-transcriptional regulation of Nedd4L expression. Yan J; Du F; Li SD; Yuan Y; Jiang JY; Li S; Li XY; Du ZX Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):48-56. PubMed ID: 28986222 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells. Su J; Ren J; Chen H; Liu B Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611 [TBL] [Abstract][Full Text] [Related]
7. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy. Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292 [TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells. Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466 [TBL] [Abstract][Full Text] [Related]
9. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy. Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813 [TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress related factor IRE1α regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy. Ke R; Wang Y; Hong S; Xiao L Exp Cell Res; 2020 Nov; 396(2):112293. PubMed ID: 32950473 [TBL] [Abstract][Full Text] [Related]
11. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation. Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195 [TBL] [Abstract][Full Text] [Related]
12. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN. Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy. Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287 [TBL] [Abstract][Full Text] [Related]
14. Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation. Tian Z; Zhang Y; Lyu X Cell Cycle; 2021 May; 20(9):874-893. PubMed ID: 33910455 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Yang F; Chung AC; Huang XR; Lan HY Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256 [TBL] [Abstract][Full Text] [Related]
16. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members. Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A Nephron; 2017; 135(4):291-306. PubMed ID: 28064277 [TBL] [Abstract][Full Text] [Related]
17. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway. Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013 [TBL] [Abstract][Full Text] [Related]
18. Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts. Huang JS; Chuang CT; Liu MH; Lin SH; Guh JY; Chuang LY Mol Cell Endocrinol; 2014 Jun; 390(1-2):45-53. PubMed ID: 24721634 [TBL] [Abstract][Full Text] [Related]
19. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy. Wang HJ; Liu H; Lin YH; Zhang SJ Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT. Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]